Cambridge Healthtech Institute’s Inaugural
Biomarkers for Immuno-Oncology
Exploring Predictive Biomarkers of Response
18-19 March 2019
Given the complexities in successfully modelling the heterogeneity of tumours and the human immune system preclinically, it is inherently difficult to develop accurate predictive biomarkers for cancer immunotherapy. Thankfully there is a significant effort
across academia and industry to do just this. Employing cutting edge techniques such as genomics, transcriptomics, proteomics and metabolomics, as well as looking into more discreet blood niches, such as circulating tumour cells and exosomes, might
just provide necessary the answers. At Cambridge Healthtech Institute’s Inaugural Biomarkers for Immuno-Oncology conference we will address this and more.
Coverage will include, but is not limited to:
- Tumour Microenvironment
- Novel Predictive Biomarkers
- Biomarkers for Combination Therapies
- Immune Profiling and Immune Monitoring
- Tumour Mutation Burden
- Single Cell Analysis
- Markers of Immune Response
- Analysis of the Microbiome
- Multiplexing and Panels
If you would like to submit a proposal to give a presentation at this meeting, please click here.
The deadline for priority consideration is 10 September 2018.
All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
For more details on the conference, please contact:
Joel Hornby, BSc Hons
Conference Director
Cambridge Healthtech Institute
Phone: (+1) 781 247 1816
Email: jhornby@healthtech.com
For partnering and sponsorship information, please contact:
Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-247-6286
Email: reymael@healthtech.com